OpenLB
Open Library of Bioscience
Advanced Search
3 Biotech
Nov, 2024;14 (11): 267.

Multifunctional gold nanoparticles for cancer theranostics.

Donald A Fernandes
Author Information
  1. Donald A Fernandes: Toronto, Canada. ORCID
PMID: 39416669 DOI: 10.1007/s13205-024-04086-4

Abstract

The diagnosis and treatment of cancer can often be challenging requiring more attractive options. Some types of cancers are more aggressive than others and symptoms for many cancers are subtle, especially in the early stages. Nanotechnology provides high sensitivity, specificity and multimodal capability for cancer detection, treatment and monitoring. In particular, metal nanoparticles (NPs) such as gold nanoparticles (AuNPs) are attractive nanosystems for researchers interested in bioimaging and therapy. The size, shape and surface of AuNPs can be modified for improving targeting and accumulation in cancer cells, for example through introduction of ligands and surface charge. The interactions of AuNPs with electromagnetic radiation (e.g., visible-near-infrared, X-rays) can be used for photothermal therapy and radiation therapy, through heat generated from light absorption and emission of Auger electrons, respectively. The subsequent expansion and high X-ray attenuation from AuNPs can be used for enhancing contrast for tumor detection (e.g., using photoacoustic, computed tomography imaging). Multi-functionality can be further extended through covalent/non-covalent functionalization, for loading additional imaging/therapeutic molecules for combination therapy and multimodal imaging. In order to cover the important aspects for designing and using AuNPs for cancer theranostics, this review focuses on the synthesis, functionalization and characterization methods that are important for AuNPs, and presents their unique properties and different applications in cancer theranostics.

Keywords

Cancer Gold nanoparticles Imaging Theranostics Therapy

References

BMJ. 2003 Jun 28;326(7404):1449 [PMID: 12829560]
Chem Commun (Camb). 2003 Sep 21;(18):2376-7 [PMID: 14518922]
Cancers (Basel). 2011 Aug 12;3(3):3279-330 [PMID: 24212956]
J Nanobiotechnology. 2017 Nov 21;15(1):85 [PMID: 29162137]
Nanotechnology. 2016 Sep 2;27(35):355601 [PMID: 27454145]
Cancer Lett. 2015 Nov 28;368(2):209-29 [PMID: 25754814]
Nano Lett. 2019 Feb 13;19(2):997-1008 [PMID: 30676760]
Biochemistry (Mosc). 2013 Nov;78(11):1228-37 [PMID: 24460937]
Angew Chem Int Ed Engl. 2018 Jul 9;57(28):8383-8394 [PMID: 29517844]
Nat Commun. 2021 Jan 4;12(1):34 [PMID: 33397947]
Drug Deliv. 2021 Dec;28(1):655-669 [PMID: 33787431]
Langmuir. 2017 Sep 26;33(38):9491-9507 [PMID: 28562058]
Nat Rev Drug Discov. 2021 Feb;20(2):101-124 [PMID: 33277608]
Theranostics. 2012;2(2):190-7 [PMID: 22375157]
Phys Med. 2018 Jan;45:127-133 [PMID: 29472077]
Biomaterials. 2015 Jan;37:425-35 [PMID: 25453970]
Front Mol Biosci. 2020 Nov 26;7:587012 [PMID: 33324678]
Colloids Surf B Biointerfaces. 2014 Sep 1;121:474-83 [PMID: 25001188]
Plasmonics. 2014;9:781-799 [PMID: 27330521]
Science. 2006 May 19;312(5776):1027-30 [PMID: 16709779]
Mol Ther Methods Clin Dev. 2016 Apr 06;3:16023 [PMID: 27088105]
Adv Mater. 2017 Sep;29(33): [PMID: 28671732]
J Nanobiotechnology. 2022 Jan 31;20(1):57 [PMID: 35101048]
Bioconjug Chem. 2017 Jan 18;28(1):124-134 [PMID: 27788580]
Adv Mater. 2018 Nov;30(45):e1801350 [PMID: 30066341]
Methods Cell Biol. 2021;162:89-114 [PMID: 33707024]
J Nanobiotechnology. 2022 Aug 31;20(1):395 [PMID: 36045386]
Front Mol Biosci. 2023 Sep 21;10:1217769 [PMID: 37808518]
J Nucl Med. 2007 Jan;48(1):73-80 [PMID: 17204701]
Photodiagnosis Photodyn Ther. 2022 Mar;37:102697 [PMID: 34936918]
J Phys Chem B. 2006 Apr 13;110(14):7232-7 [PMID: 16599492]
J Biomed Opt. 2015 May;20(5):51043 [PMID: 26021715]
Med Phys. 2013 May;40(5):051901 [PMID: 23635271]
Chem Commun (Camb). 2013 Jan 4;49(1):16-8 [PMID: 23032158]
EJNMMI Radiopharm Chem. 2022 Apr 25;7(1):8 [PMID: 35467307]
Cold Spring Harb Protoc. 2014 Oct 01;2014(10):pdb.top071795 [PMID: 25275114]
Toxicol Appl Pharmacol. 2016 Nov 1;310:98-107 [PMID: 27634460]
J Nanobiotechnology. 2018 Sep 19;16(1):71 [PMID: 30231877]
Biosens Bioelectron. 2018 Jul 15;111:102-116 [PMID: 29660581]
Chem Soc Rev. 2014 Nov 7;43(21):7267-78 [PMID: 25099190]
J Nanobiotechnology. 2011 May 10;9:16 [PMID: 21569249]
J Colloid Interface Sci. 2008 Jul 15;323(2):247-54 [PMID: 18486946]
Int J Pharm. 2015 Apr 30;484(1-2):252-67 [PMID: 25701627]
Nanomaterials (Basel). 2022 Aug 17;12(16): [PMID: 36014691]
Clin Cancer Res. 2005 May 1;11(9):3530-4 [PMID: 15867256]
Sci Transl Med. 2013 Oct 30;5(209):209ra152 [PMID: 24174328]
ChemistryOpen. 2019 Jun 11;8(6):705-711 [PMID: 31205847]
Chemistry. 2010 Sep 3;16(33):10103-12 [PMID: 20623564]
J Nanobiotechnology. 2022 Oct 15;20(1):450 [PMID: 36243718]
Nanomedicine (Lond). 2012 Dec;7(12):1895-906 [PMID: 23249333]
J Med Chem. 2017 Sep 28;60(18):7617-7635 [PMID: 28505442]
Pharmacol Res. 2017 Jun;120:258-266 [PMID: 28396092]
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Nov;8(6):814-841 [PMID: 27040463]
ACS Nano. 2013 Oct 22;7(10):9384-95 [PMID: 24010584]
J Biomed Opt. 2020 Jan;25(1):1-11 [PMID: 31970944]
Molecules. 2017 Aug 31;22(9): [PMID: 28858253]
Methods Mol Biol. 2012;906:473-82 [PMID: 22791457]
J Colloid Interface Sci. 2023 Mar 15;634:601-609 [PMID: 36549208]
ACS Nano. 2013 Aug 27;7(8):6782-95 [PMID: 23822176]
Adv Healthc Mater. 2014 Aug;3(8):1194-9 [PMID: 24652754]
Chem Commun (Camb). 2005 Sep 7;(33):4181-3 [PMID: 16100596]
J Control Release. 2018 Jul 28;282:101-109 [PMID: 29526739]
Clin Cancer Res. 2009 Feb 1;15(3):876-86 [PMID: 19188158]
Nanoscale. 2015 Dec 14;7(46):19722-31 [PMID: 26556382]
Front Pharmacol. 2023 Mar 27;14:1134758 [PMID: 37050902]
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9138-43 [PMID: 12886020]
J Colloid Interface Sci. 2015 Feb 1;439:28-33 [PMID: 25463172]
Nanomedicine (Lond). 2015 Jan;10(2):299-320 [PMID: 25600972]
ACS Omega. 2021 Mar 24;6(13):9188-9195 [PMID: 33842787]
Sci Rep. 2020 Feb 25;10(1):3362 [PMID: 32099027]
Anal Chim Acta. 2018 Nov 15;1031:1-14 [PMID: 30119727]
Nanotheranostics. 2017 Jul 7;1(3):326-337 [PMID: 29071196]
Proc Natl Acad Sci U S A. 2021 Aug 24;118(34): [PMID: 34408023]
Soft Matter. 2021 Aug 28;17(32):7487-7497 [PMID: 34323887]
Photodiagnosis Photodyn Ther. 2021 Mar;33:102144 [PMID: 33307234]
Adv Sci (Weinh). 2016 Dec 16;4(3):1600279 [PMID: 28331783]
Cancer Cell. 2012 Mar 20;21(3):309-22 [PMID: 22439926]
Clin Cancer Res. 2010 Dec 15;16(24):6139-49 [PMID: 20876255]
J Am Chem Soc. 2006 Feb 15;128(6):2115-20 [PMID: 16464114]
Nanomedicine (Lond). 2016 Mar;11(6):673-92 [PMID: 27003448]
Eur J Histochem. 2018 Mar 15;62(1):2841 [PMID: 29569878]
Biomaterials. 2008 Apr;29(12):1912-9 [PMID: 18242692]
Nanoscale. 2018 Apr 19;10(15):6900-6910 [PMID: 29561559]
Small. 2005 Jan;1(1):48-63 [PMID: 17193348]
Pharmacol Res. 2022 Dec;186:106522 [PMID: 36283629]
Nanoscale Res Lett. 2007 Aug 15;2(9):430-41 [PMID: 21794189]
Emergent Mater. 2022;5(6):1593-1615 [PMID: 35005431]
Photodiagnosis Photodyn Ther. 2021 Mar;33:102186 [PMID: 33497816]
Chem Rev. 2019 Apr 24;119(8):4819-4880 [PMID: 30920815]
ACS Appl Mater Interfaces. 2018 May 30;10(21):17792-17808 [PMID: 29733576]
Langmuir. 2014 Sep 2;30(34):10143-50 [PMID: 25111614]
Nat Commun. 2015 Jun 26;6:7571 [PMID: 26113393]
Front Cell Dev Biol. 2020 Feb 13;8:41 [PMID: 32117972]
Curr Cancer Drug Targets. 2018;18(8):737-748 [PMID: 28669345]
Nat Rev Mol Cell Biol. 2007 Mar;8(3):221-33 [PMID: 17318226]
ACS Appl Mater Interfaces. 2014 Aug 27;6(16):14266-77 [PMID: 25090604]
Nanomedicine (Lond). 2018 Jun;13(11):1371-1383 [PMID: 29749804]
J Biomed Opt. 2023 Dec;28(12):121205 [PMID: 37304059]
ACS Nano. 2014 Jun 24;8(6):5852-62 [PMID: 24824865]
Eur J Pharm Biopharm. 2010 Jan;74(1):2-13 [PMID: 19755155]
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49 [PMID: 38230766]
Bioconjug Chem. 2016 Oct 19;27(10):2225-2238 [PMID: 27547843]
ACS Nano. 2015 Mar 24;9(3):2783-91 [PMID: 25665929]
Sci Transl Med. 2021 Mar 10;13(584): [PMID: 33692132]
J Am Chem Soc. 2004 Jul 21;126(28):8648-9 [PMID: 15250706]
Sci Rep. 2015 Oct 28;5:15675 [PMID: 26507179]
Materials (Basel). 2020 Apr 24;13(8): [PMID: 32344722]
Int J Mol Sci. 2022 Apr 30;23(9): [PMID: 35563414]
ACS Nano. 2009 Feb 24;3(2):395-401 [PMID: 19236077]
Nanomedicine. 2011 Oct;7(5):580-7 [PMID: 21333757]
Sci Rep. 2018 Mar 2;8(1):3943 [PMID: 29500365]
Photodiagnosis Photodyn Ther. 2022 Sep;39:102979 [PMID: 35728753]
Bioconjug Chem. 2019 Jun 19;30(6):1724-1733 [PMID: 31067032]
Langmuir. 2010 Jul 20;26(14):12307-13 [PMID: 20557088]
Photochem Photobiol Sci. 2018 Nov 1;17(11):1534-1552 [PMID: 30118115]
J Med Imaging Radiat Sci. 2010 Jun;41(2):87-109 [PMID: 31051822]
Angew Chem Int Ed Engl. 2016 Dec 5;55(49):15297-15300 [PMID: 27862808]
J Phys Chem B. 2006 Aug 17;110(32):15700-7 [PMID: 16898714]
Sci Rep. 2017 Jun 19;7(1):3827 [PMID: 28630477]
Mol Imaging. 2018 Jan-Dec;17:1536012118775827 [PMID: 29873290]
J Control Release. 2010 Nov 20;148(1):122-127 [PMID: 20547192]
Int J Nanomedicine. 2014 Nov 21;9:5415-30 [PMID: 25473280]
Cancer Med. 2021 Jan;10(1):257-268 [PMID: 33141513]
ACS Appl Bio Mater. 2023 Feb 20;6(2):349-364 [PMID: 36700563]
Adv Drug Deliv Rev. 2020;154-155:123-141 [PMID: 32721459]
Spectrochim Acta A Mol Biomol Spectrosc. 2013 Feb;102:15-23 [PMID: 23211617]
Pharmaceutics. 2022 Oct 20;14(10): [PMID: 36297675]
Nanomaterials (Basel). 2020 Nov 27;10(12): [PMID: 33260990]
Nanoscale Res Lett. 2018 Oct 4;13(1):313 [PMID: 30288620]
Methods Mol Biol. 2013;1025:3-8 [PMID: 23918325]
Comput Math Methods Med. 2015;2015:284360 [PMID: 26136812]
Nanoscale Adv. 2020 Jun 10;2(7):2859-2869 [PMID: 36132415]
Adv Sci (Weinh). 2020 Jul 01;7(16):2001048 [PMID: 32832360]
Curr Biol. 2020 Aug 17;30(16):R921-R925 [PMID: 32810447]
Anal Chem. 2012 Aug 7;84(15):6312-6 [PMID: 22816618]
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231191493 [PMID: 37642945]
Theranostics. 2017 Apr 10;7(7):1875-1889 [PMID: 28638474]
J Colloid Interface Sci. 2005 Aug 15;288(2):396-401 [PMID: 15927605]
Prog Mater Sci. 2019 Jan;99:1-26 [PMID: 30568319]
J Mater Chem B. 2020 Jun 21;8(23):5131-5142 [PMID: 32420578]
Mater Today (Kidlington). 2013 Jul;16(7-8):290-296 [PMID: 25525408]
Acc Chem Res. 2023 Dec 5;56(23):3369-3378 [PMID: 37966025]
ACS Nano. 2015 Jul 28;9(7):7052-71 [PMID: 26147899]
Nat Nanotechnol. 2021 Mar;16(3):266-276 [PMID: 33712737]
Pharmaceutics. 2021 Aug 25;13(9): [PMID: 34575408]
Nanoscale Res Lett. 2017 Dec;12(1):25 [PMID: 28070836]
Mater Sci Eng C Mater Biol Appl. 2019 May;98:1252-1276 [PMID: 30813007]
Philos Trans A Math Phys Eng Sci. 2010 Mar 28;368(1915):1333-83 [PMID: 20156828]
Nanomedicine. 2011 Oct;7(5):604-14 [PMID: 21333754]
Acta Biomater. 2015 Jan;11:393-403 [PMID: 25246314]
Int J Mol Sci. 2020 May 26;21(11): [PMID: 32466428]
Talanta. 2007 Jul 31;72(5):1800-4 [PMID: 19071835]
Ultrason Sonochem. 2021 Jan;70:105274 [PMID: 32771910]
J Photochem Photobiol B. 2021 May;218:112110 [PMID: 33865007]
Nanoscale Res Lett. 2011 Aug 30;6(1):514 [PMID: 21878120]
Biomed Microdevices. 2021 Sep 21;23(4):46 [PMID: 34546397]
Front Bioeng Biotechnol. 2022 Apr 06;10:874742 [PMID: 35464722]
Nano Lett. 2011 Apr 13;11(4):1733-8 [PMID: 21410218]
Cell. 2000 Jan 7;100(1):57-70 [PMID: 10647931]
Int J Toxicol. 2016 Jan-Feb;35(1):38-46 [PMID: 26296672]
Phys Chem Chem Phys. 2011 Jun 7;13(21):9929-41 [PMID: 21380462]
Nanoscale. 2015 Jun 28;7(24):10634-40 [PMID: 26022234]
Curr Treat Options Oncol. 2007 Dec;8(6):417-27 [PMID: 18066703]
J Phys Chem B. 2005 Nov 10;109(44):20673-5 [PMID: 16853678]
J Am Chem Soc. 2002 Mar 13;124(10):2305-11 [PMID: 11878985]
Nanomedicine (Lond). 2017 May;12(10):1095-1099 [PMID: 28447906]
Mater Sci Eng C Mater Biol Appl. 2021 Aug;127:112190 [PMID: 34225846]
Acta Biomater. 2017 Jan 1;47:124-134 [PMID: 27721008]
RSC Adv. 2021 Aug 2;11(42):26344-26353 [PMID: 35479447]
J Biomed Opt. 2014 May;19(5):056004 [PMID: 24805808]
Int J Radiat Biol. 2017 Feb;93(2):214-221 [PMID: 27705054]
Expert Opin Drug Deliv. 2021 Feb;18(2):205-227 [PMID: 32969740]
Biomaterials. 2020 Feb;232:119677 [PMID: 31865193]
J Am Chem Soc. 2009 Feb 4;131(4):1360-1 [PMID: 19133720]
Nanomicro Lett. 2021 Jan 16;13(1):58 [PMID: 34138261]
Int J Nanomedicine. 2020 Jan 13;15:181-197 [PMID: 32021173]
Small. 2013 Nov 11;9(21):3678-84 [PMID: 23661612]
Crit Rev Oncol Hematol. 2019 May;137:57-83 [PMID: 31014516]
Int J Nanomedicine. 2019 Aug 09;14:6387-6406 [PMID: 31496693]
BMC Chem. 2022 Nov 9;16(1):90 [PMID: 36352463]
Chemphyschem. 2015 Mar 16;16(4):775-81 [PMID: 25598360]
J Funct Biomater. 2021 Dec 03;12(4): [PMID: 34940549]
Expert Opin Drug Deliv. 2010 Apr;7(4):535-50 [PMID: 20201712]
Cancer Imaging. 2016 Aug 03;16(1):20 [PMID: 27487932]
Biochem Biophys Rep. 2021 Apr 10;26:100991 [PMID: 33912692]
J Nanobiotechnology. 2013 Jul 15;11:25 [PMID: 23855448]
Biomed Pharmacother. 2019 Aug;116:109006 [PMID: 31152925]
Int J Nanomedicine. 2015 Mar 06;10:1727-41 [PMID: 25834422]
Ayu. 2012 Jul;33(3):365-7 [PMID: 23723642]
Nano Today. 2009 Oct 1;4(5):399-413 [PMID: 20161038]
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18590-18596 [PMID: 31451630]
Nature. 2005 Dec 15;438(7070):967-74 [PMID: 16355214]
Biomaterials. 2015 Aug;60:100-10 [PMID: 25988725]
Small. 2022 Sep;18(37):e2201324 [PMID: 35905490]
Biol Cell. 2019 Jan;111(1):1-17 [PMID: 30302777]
J Chem Educ. 2021 Feb 9;98(2):546-552 [PMID: 34024937]
Kona. 2020 Jan 10;37:224-232 [PMID: 32153313]
J Inorg Biochem. 2020 Aug;209:111117 [PMID: 32473483]
Theranostics. 2020 May 20;10(15):6774-6789 [PMID: 32550903]
J Pharm Pharmacol. 2019 Aug;71(8):1185-1198 [PMID: 31049986]
Adv Drug Deliv Rev. 2014 Feb;66:2-25 [PMID: 24270007]
Lancet Oncol. 2003 Sep;4(9):529-36 [PMID: 12965273]
Nanomedicine (Lond). 2009 Jun;4(4):401-10 [PMID: 19505243]
Adv Drug Deliv Rev. 2013 May;65(5):607-21 [PMID: 22664231]
Chem Soc Rev. 2022 Dec 12;51(24):9882-9916 [PMID: 36420611]
Annu Rev Phys Chem. 2008;59:659-83 [PMID: 18393682]
J Control Release. 2013 Oct 28;171(2):241-50 [PMID: 23867285]
Journal Article Review

Word Cloud

Similar Articles

Cited By